1. Home
  2. VIR vs ALGT Comparison

VIR vs ALGT Comparison

Compare VIR & ALGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIR
  • ALGT
  • Stock Information
  • Founded
  • VIR 2016
  • ALGT 1997
  • Country
  • VIR United States
  • ALGT United States
  • Employees
  • VIR N/A
  • ALGT N/A
  • Industry
  • VIR Biotechnology: Pharmaceutical Preparations
  • ALGT Air Freight/Delivery Services
  • Sector
  • VIR Health Care
  • ALGT Consumer Discretionary
  • Exchange
  • VIR Nasdaq
  • ALGT Nasdaq
  • Market Cap
  • VIR 1.0B
  • ALGT 1.5B
  • IPO Year
  • VIR 2019
  • ALGT 2006
  • Fundamental
  • Price
  • VIR $7.27
  • ALGT $91.95
  • Analyst Decision
  • VIR Buy
  • ALGT Hold
  • Analyst Count
  • VIR 5
  • ALGT 9
  • Target Price
  • VIR $36.40
  • ALGT $73.78
  • AVG Volume (30 Days)
  • VIR 1.2M
  • ALGT 304.9K
  • Earning Date
  • VIR 02-20-2025
  • ALGT 02-03-2025
  • Dividend Yield
  • VIR N/A
  • ALGT 1.27%
  • EPS Growth
  • VIR N/A
  • ALGT N/A
  • EPS
  • VIR N/A
  • ALGT N/A
  • Revenue
  • VIR $78,618,000.00
  • ALGT $2,495,886,000.00
  • Revenue This Year
  • VIR N/A
  • ALGT $1.60
  • Revenue Next Year
  • VIR N/A
  • ALGT $11.25
  • P/E Ratio
  • VIR N/A
  • ALGT N/A
  • Revenue Growth
  • VIR N/A
  • ALGT N/A
  • 52 Week Low
  • VIR $6.56
  • ALGT $36.09
  • 52 Week High
  • VIR $13.09
  • ALGT $96.93
  • Technical
  • Relative Strength Index (RSI)
  • VIR 42.92
  • ALGT 65.75
  • Support Level
  • VIR $7.22
  • ALGT $80.57
  • Resistance Level
  • VIR $7.64
  • ALGT $92.22
  • Average True Range (ATR)
  • VIR 0.35
  • ALGT 4.23
  • MACD
  • VIR -0.01
  • ALGT 0.33
  • Stochastic Oscillator
  • VIR 30.43
  • ALGT 71.27

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About ALGT Allegiant Travel Company

Allegiant Travel Co provides travel services in the United States. It sells air transportation on a stand-alone basis or bundled with air-related and third-party services and products. Customers may also purchase fixed-fee flying arrangements to receive charter service on a year-round and ad hoc basis. Additionally, customers may purchase hotel rooms, ground transportation, and other attractions (for example, entertainment show tickets) to accommodate a trip. The company's operating segment includes Airline, Sunseeker Resort, and other non-airlines. Customers purchase travel tickets at airport ticket counters, online, or through its telephone reservation center.

Share on Social Networks: